Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC)

被引：0
|
作者：
Gupta, Santosh
Halabi, Susan
Kemeny, Gabor
Anand, Monika
Nanus, David M.
Giannakakou, Paraskevi
George, Daniel J.
Gregory, Simon
Armstrong, Andrew J.
机构：
[1] Duke Univ, Duke Canc Inst, Durham, NC USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Duke Univ, Durham, NC USA
[4] Sandra & Edward Meyer Canc Ctr, New York, NY USA
[5] Weill Cornell Med, Meyer Canc Ctr, New York, NY USA
[6] Duke Univ, Sch Med, Durham, NC USA
[7] Duke Canc Inst, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
147
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer
    Gupta, Santosh
    Halabi, Susan
    Kemeny, Gabor
    Anand, Monika
    Giannakakou, Paraskevi
    Nanus, David M.
    George, Daniel J.
    Gregory, Simon G.
    Armstrong, Andrew J.
    MOLECULAR CANCER RESEARCH, 2021, 19 (06) : 1040 - 1050
  • [2] Evaluation of clinical phenotype, survival, and circulating tumor cell (CTC) enumeration in men with metastatic castration-resistant prostate cancer (mCRPC).
    Bitting, Rhonda Lynn
    Healy, Patrick
    Halabi, Susan
    George, Daniel J.
    Ko, Jung Hyun
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Impact of circulating tumor cell (CTC) nucleus size on outcomes with abiraterone acetate (AA) therapy in men with metastatic castration-resistant prostate cancer (mCRPC)
    Gill, David Michael
    Agarwal, Neeraj
    Hahn, Andrew W.
    Johnson, Eric
    Poole, Austin
    Carroll, Emma
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [4] Chromosomal instability (CIN) biomarker in circulating tumor cells (CTC) may predict for therapy resistance in metastatic castration-resistant prostate cancer (mCRPC)
    Keegan, N. M.
    Schonhoft, J.
    Barnett, E.
    Cohn, E. D.
    Zhao, J. L.
    Carbone, E. A.
    Zanone, M. R.
    Anderson, A.
    Wenstrup, R.
    Scher, H. I.
    ANNALS OF ONCOLOGY, 2021, 32 : S653 - S653
  • [5] Circulating tumor cell (CTC) rise and outcome in patients with metastatic castration-resistant prostate cancer (mCRPC) with low baseline CTC counts.
    Lorente, David
    Olmos, David
    Mateo, Joaquin
    Zafeiriou, Zafeiris
    Rescigno, Pasquale
    Bianchini, Diletta
    Mehra, Niven
    Molina, Arturo
    Kheoh, Thian
    Baeten, Kurt
    Mccormack, Robert Thomas
    Terstappen, Leon W. M. M.
    Scher, Howard I.
    De Bono, Johann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Molecular and genomic characterization of invasive circulating tumor cells (iCTCs) from men with metastatic castration-resistant prostate cancer (mCRPC)
    Friedlander, Terence W.
    Premasekharan, Gayatri
    Vy Ngo
    Doty, Shaun
    Harris, Anna
    Winter, Michael
    Gilbert, Elizabeth
    Craik, Charles
    Paris, Pamela
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [7] Molecular and genomic characterization of invasive circulating tumor cells (iCTCs) from men with metastatic castration-resistant prostate cancer (mCRPC).
    Friedlander, Terence W.
    Premasekharan, Gayatri
    Ngo, Vy
    Hang, Evelyn
    Graff, Julie Nicole
    Ryan, Charles J.
    Paris, Pamela
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Analysis of genomic alterations in matched circulating tumor cell DNA (CTC DNA) and plasma tumor DNA (ctDNA) in men with metastatic castration resistant prostate cancer (mCRPC).
    Gupta, Santosh
    Hovelson, Daniel H.
    Tomlins, Scott A.
    Kemeny, Gabor
    Liu, Chia-Jen
    George, Daniel J.
    Rothwell, Colin
    Anand, Monika
    Nanus, David M.
    Giannakakou, Paraskevi
    Gregory, Simon
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Baseline analysis of circulating tumor cell (CTC) enumeration and androgen receptor (AR) localization in men with metastatic castration-resistant prostate cancer (mCRPC) in TAXYNERGY.
    Tagawa, Scott T.
    Galletti, Giuseppe
    Antonarakis, Emmanuel S.
    Tasaki, Shinsuke
    Gjyrezi, Ada
    Worroll, Daniel
    Portella, Luigi
    Kirby, Brian J.
    Stewart, John
    Zaher, Atef
    Saad, Fred
    Vanhuyse, Marie
    Suri, Shalu
    Lannin, Timothy B.
    Gruber, Conor
    Pratt, Erica
    Sonpavde, Guru
    Eisenberger, Mario A.
    Nanus, David M.
    Giannakakou, Paraskevi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Chromosomal instability (CIN) in circulating tumor cells (CTC) predicts for taxane sensitivity in metastatic castration-resistant prostate cancer (mCRPC).
    Keegan, Niamh M.
    Arfe, Andrea
    Barnett, Ethan
    Cohn, Erica Dayan
    Zhao, Jimmy
    Carbone, Emily
    Zanone, Michelle
    Anderson, Amanda
    Wenstrup, Rick
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345